Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Watertown, USA
134 Coolidge Avenue
Watertown, MA, 02472
USA

People

Founder & Board of Directors
Founder
Founder, Board of Directors
President & CEO
Vice President of Product Development
Vice President of Medicinal Chemistry
Board Member
Board Member
Show All People

Funding

TOTAL $24.8M
FUNDING TOTAL $24.8M
Series A, 1/2012
Flagship Ventures
New Enterprise Associates
$2.8M
Series B, 12/2013
NanoDimension
Flagship Ventures
New Enterprise Associates
$21M
Venture Round, 3/2014
$1M

Tags

Blend Therapeutics

Blend is discovering and developing integrative combination medicines with the unprecedented ability to precisely control each agent’s therapeutic action in concert. Using their proprietary Maestro™ platform, they design and integrate drugs to target distinct disease pathways with optimal efficacy and safety. Blend was founded by three leaders in the fields of chemistry and nanomedicine from MIT and Harvard Medical School: Dr. Robert Langer and Dr. Stephen Lippard of MIT, and Dr. Omid Farokhzad of Harvard Medical School.

Recent Milestones

Videos

Screenshots

Blend Therapeutics screenshot
Above: Blend Therapeutics
Uploaded: 1/9/12

Sources

  1. Blend debuts with $2.8 million (biocentury.com) [edit]
  2. SEC D/A (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy